Robert Young Net Worth & Insider Trades

Robert Young - Director, Aveo Pharmaceuticals, Inc

As of June 30, 2020

What is Robert Young's Net Worth?

The current estimated net worth of Aveo Pharmaceuticals, Inc's Director, Robert Young, is estimated to be about $478.8K . Robert Young owns about 10,000 units of Aveo Pharmaceuticals, Inc common stock. In the last 10 years at Aveo Pharmaceuticals, Inc, Robert Young has sold an estimated value of $68.75K worth.

What is Robert Young's Past Insider Trading?

Robert Young's largest purchase order was 6,500 units , worth over $48.36K on August 22, 2011. Robert Young's largest sale order was 4,361 units , worth over $68.75K on August 22, 2011. In total, Robert Young has made about 21 transactions over 10 years of their time at Aveo Pharmaceuticals, Inc. Robert Young usually trades in June, with the busiest year in 2013. The most recent transaction was a purchase order of 990 units , worth over $6.53K on February 20, 2013.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ROBERT YOUNG

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Aveo Pharmaceuticals, Inc's Past Insider Trades?

Aveo Pharmaceuticals, Inc's most recent insider trade came on September 3, 2021 by Michael Bailey who bought 15,000 units worth $97.2K . In the last 11 years, insiders at Aveo Pharmaceuticals, Inc have sold an estimated value of $24.26M and bought an estimated value of $220.44M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are William Slichenmyer, Chief Medical Officer,  Anthony Evnin, Director,  and Michael Bailey, President & CEO .

AVEO PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...